StockData
Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc. (MRVI) stock

MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30170% above fair value
$7.28−0.12 (-1.62%)

Close on Nov 17, 2026Market cap $1.89BP/E –Yield –

Maravai LifeSciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Maravai LifeSciences's price to sales ratio was 5.4× on Nov 11, 2026, against 2.7× a year earlier. Over the last 5 years it ranged from 1.1× to 61.8×, with a median of 3.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.4×+3.0
2025Dec 31, 20252.4×−0.2
2024Dec 31, 20242.7×+0.1
2023Dec 29, 20232.5×−1.0
2022Dec 30, 20223.6×−58.3
2021Jan 29, 202161.8×+12.0
2020Dec 31, 202049.8×–

More Maravai LifeSciences figures

See a number that looks wrong?